Livia De Paolis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Livia De Paolis has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Elisabetta Razzuoli
Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, 16129 Genoa, Italy
5 shared publications - Filippo Dell’aNno
National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Genoa, Italy
4 shared publications - Floriana Fruscione
National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Piazza Borgo Pila 39/24, 16129 Genoa, Italy
3 shared publications - Chiara Grazia De Ciucis
National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle D’Aosta, 16129 Genova, Italy
2 shared publications - Katia Cappelli
Department of Veterinary Medicine, University of Perugia, Perugia, Italy
2 shared publications - Lisa Guardone
Department of Veterinary Science, University of Pisa, Viale delle Piagge 2, 56124 Pisa, Italy
2 shared publications
Latest Publications
- Open Access
Host-Specific Circulation and Molecular Diversity of Babesia, Hepatozoon and Bartonella Species Among Wild Carnivores in Northwestern Italy
Vector-borne diseases (VBDs) represent a concern for animal and public health, and wildlife surveillance is valuable for their monitoring. The occurrence, molecular diversity and host distribution of tick-borne protozoa (TBP: Babesia spp., Theileria spp. and Hepatozoon spp.) and Bartonella spp. were investigated in wild carnivores from three regions of northwestern Italy. Spleen samples from 690 wild carnivores were screened for TBP and/or Bartonella spp. by PCR followed by sequencing. Among the 503 carnivores screened for TBP, 197 animals (39.2%) tested positive for at least one targeted protozoan species, including 87 positives for Babesia spp. (17.3%) and 120 for Hepatozoon spp. (23.9%). Bartonella spp. DNA was additionally detected in only one of the 363 animals tested (0.3%). Sequencing identified Babesia sp. badger types A and C in badgers, B. vulpes in foxes and B. canis in wolves, Hepatozoon canis in wolves and foxes, H. martis in stone martens and Hepatozoon sp. in stone and pine martens. Phylogenetic analyses supported the host-associated clustering of the detected lineages, confirming the molecular identification. These findings indicate the frequent occurrence of different TBP in wild carnivores from northwestern Italy, with marked host associated patterns, contributing to our understanding of VBD epidemiology with a One Health approach.
Open AccessHost-Specific Circulation and Molecular Diversity of Babesia, Hepatozoon and Bartonella Species Among Wild Carnivores in Northwestern Italy
Vector-borne diseases (VBDs) represent a concern for animal and public health, and wildlife surveillance is valuable for their monitoring. The occurrence, molecular diversity and host distribution of tick-borne protozoa (TBP: Babesia spp., Theileria spp. and Hepatozoon spp.) and Bartonella spp. were investigated in wild carnivores from three regions of northwestern Italy. Spleen samples from 690 wild carnivores were screened for TBP and/or Bartonella spp. by PCR followed by sequencing. Among the 503 carnivores screened for TBP, 197 animals (39.2%) tested positive for at least one targeted protozoan species, including 87 positives for Babesia spp. (17.3%) and 120 for Hepatozoon spp. (23.9%). Bartonella spp. DNA was additionally detected in only one of the 363 animals tested (0.3%). Sequencing identified Babesia sp. badger types A and C in badgers, B. vulpes in foxes and B. canis in wolves, Hepatozoon canis in wolves and foxes, H. martis in stone martens and Hepatozoon sp. in stone and pine martens. Phylogenetic analyses supported the host-associated clustering of the detected lineages, confirming the molecular identification. These findings indicate the frequent occurrence of different TBP in wild carnivores from northwestern Italy, with marked host associated patterns, contributing to our understanding of VBD epidemiology with a One Health approach.
- Open Access
Equine Sarcoid: From BPV-Driven Oncogenesis to Host-Sustained Tumor Persistence
Equine sarcoid is the most common cutaneous neoplasm of equids and represents a distinctive model of virus-associated tumor persistence. Although bovine papillomaviruses, particularly BPV-1 and BPV-2, are recognized as the main etiological agents, viral infection alone does not fully explain the clinical heterogeneity, frequent recurrence, and limited spontaneous regression of these lesions. This review summarizes current evidence on the molecular and cellular mechanisms underlying equine sarcoid pathogenesis, with emphasis on the interaction between BPV infection, host signaling pathways, tumor microenvironment dynamics, and multi-omic evidence of host regulatory networks. BPV oncoproteins, especially E5, promote fibroblast transformation through PDGFβR activation, downstream PI3K/AKT, MAPK and p38 signaling, altered cell survival, and immune evasion mediated by impaired antigen presentation. However, sarcoid persistence appears to depend on broader host-driven processes, including extracellular matrix remodeling, activated fibroblastic and myofibroblastic phenotypes, chronic inflammatory signaling, and ineffective immune clearance. Recent transcriptomic and epigenomic studies further indicate that long non-coding RNAs, DNA methylation changes, circulating microRNAs, and recently identified virus–host chimeric transcripts may contribute to stabilization of the neoplastic phenotype and may represent future biomarkers. Overall, this review proposes a virus-initiated, host-sustained conceptual framework for equine sarcoid pathogenesis, in which viral oncogene activity and host tissue reprogramming cooperate to promote lesion persistence, recurrence, and therapeutic resistance.
Open AccessEquine Sarcoid: From BPV-Driven Oncogenesis to Host-Sustained Tumor Persistence
Equine sarcoid is the most common cutaneous neoplasm of equids and represents a distinctive model of virus-associated tumor persistence. Although bovine papillomaviruses, particularly BPV-1 and BPV-2, are recognized as the main etiological agents, viral infection alone does not fully explain the clinical heterogeneity, frequent recurrence, and limited spontaneous regression of these lesions. This review summarizes current evidence on the molecular and cellular mechanisms underlying equine sarcoid pathogenesis, with emphasis on the interaction between BPV infection, host signaling pathways, tumor microenvironment dynamics, and multi-omic evidence of host regulatory networks. BPV oncoproteins, especially E5, promote fibroblast transformation through PDGFβR activation, downstream PI3K/AKT, MAPK and p38 signaling, altered cell survival, and immune evasion mediated by impaired antigen presentation. However, sarcoid persistence appears to depend on broader host-driven processes, including extracellular matrix remodeling, activated fibroblastic and myofibroblastic phenotypes, chronic inflammatory signaling, and ineffective immune clearance. Recent transcriptomic and epigenomic studies further indicate that long non-coding RNAs, DNA methylation changes, circulating microRNAs, and recently identified virus–host chimeric transcripts may contribute to stabilization of the neoplastic phenotype and may represent future biomarkers. Overall, this review proposes a virus-initiated, host-sustained conceptual framework for equine sarcoid pathogenesis, in which viral oncogene activity and host tissue reprogramming cooperate to promote lesion persistence, recurrence, and therapeutic resistance.
- Open Access
- 9 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 64
Epidemiology of Splenic Lesions in Dogs Undergoing Splenectomy—Pathological Characterization and Risk Factors
Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.
- 9 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 64
Open AccessEpidemiology of Splenic Lesions in Dogs Undergoing Splenectomy—Pathological Characterization and Risk Factors
Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.
- Open Access
- 11 September 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 119005
Cadmium and cancer: A study on canine tumours and environmental bioindicators (Sus scrofa)
- 11 September 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 119005
Open AccessCadmium and cancer: A study on canine tumours and environmental bioindicators (Sus scrofa)
- Open Access
- 18 October 2024
- Published by Elsevier in Research in Veterinary Science
- Vol. 180, 105438
Evaluation of attenuated Salmonella Typhimurium (STMΔznuABC) anticancer activity on canine mammary cancer-associated fibroblasts
- 18 October 2024
- Published by Elsevier in Research in Veterinary Science
- Vol. 180, 105438
Open AccessEvaluation of attenuated Salmonella Typhimurium (STMΔznuABC) anticancer activity on canine mammary cancer-associated fibroblasts